Ultra Drugs Formulations Private Limited, a active private limited company, was established on 04 February 2020 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100HP2020PTC007802. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
Employing 74 professional, Its leadership includes Sandeep Kumar Arora (Director), Minna Jakhar (Director), Sangram Singh (Nominee Director). It holds ₹24.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Khatta/Khatauni No. 38/39 Khasra No. 338/278 & 279 Village Manakpur, Baddi, Himachal Pradesh, 173205.
U85100HP2020PTC007802
007802
04 February 2020
₹3.00 Cr
₹3.00 Cr
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Ultra Drugs Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Kumar Arora | Director | 04 Feb 2020 | Current |
| Minna Jakhar | Director | 04 Feb 2020 | Current |
| Sangram Singh | Nominee Director | 04 Feb 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ultra Drugs Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Ultra Drugs Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹248,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2025 | Others | ₹10.60 Cr | Open |
| 16 Feb 2022 | Hdfc Bank Limited | ₹14.20 Cr | Open |
Explore comprehensive loan charge details -
Ultra Drugs Formulations has a workforce of 74 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ultra Drugs Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Drugs Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 10.60 Cr with Charge ID 101115964 was registered on 26 Jun 2025. was completed.
The activity Ultra Drugs Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Ultra Drugs Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 14.20 Cr registered on 16 Feb 2022 with Charge ID 100551319 was modified on 03 Nov 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 14.20 Cr with Charge ID 100551319 was registered on 16 Feb 2022. was recorded as a recent event.
The activity Sandeep Kumar Arora was appointed as a Director was appointed as a Director on 04 Feb 2020 & has been associated with this company since 5 years 9 months . was completed.
The CIN of Ultra Drugs Formulations Private Limited is U85100HP2020PTC007802.
Ultra Drugs Formulations Private Limited is headquartered at Khatta/Khatauni No. 38/39 Khasra No. 338/278 & 279 Village Manakpur, Baddi, Himachal Pradesh, 173205.
Ultra Drugs Formulations Private Limited was incorporated on 04 February 2020.
The current directors of Ultra Drugs Formulations Private Limited are
The primary industry of Ultra Drugs Formulations Private Limited is Manufacturing.
Ultra Drugs Formulations Private Limited is unlisted.
The authorized capital of Ultra Drugs Formulations Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX